Flow Cytometry is a laser-based technique which is used to detect and analyze chemical or physical characteristics of cells or particles, which is most commonly used to evaluate bone marrow, peripheral blood and other fluids in your body. Flow cytometry is continuously going through new developments with availability of robust photo detectors and new laser emitters, use of LED lamps as emitter, and changes in analytical capacity (multidimensional analysis software). Furthermore, new approaches combining existing technologies with routine laboratory procedures, such as imaging, which capture of images of cells possible in real time as they pass by the interrogation point are some of the major advancements in flow cytometry. The process also finds application in cytology, hematology, immunology, and microbiology, among other research fields
The global flow cytometry market is estimated to be valued at US$ 5,688.7 million in 2022 and is expected to exhibit a CAGR of 10.4% during the forecast period (2022-2030).
Figure 1. Global Flow Cytometry Market Share (%), by Technology, 2022
Global Flow Cytometry Market - Drivers
Increasing adoption of inorganic strategies such as product launch by key market players is expected to drive the global flow cytometry market growth over the forecast period. For instance, in June 2022, BD, a medical technology company, announced that they had launched an advanced flow cytometry system that sort cells based on their inner workings. This system will sort and characterized the myriad cells that makes up the human body. It aims to profile individual cells based on their visual characteristics in addition to various protein biomarkers, at a rate of up to 15,000 cells per second.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2021 | Market Size in 2022: | US$ 5,688.7 Mn |
| Historical Data for: | 2017 to 2020 | Forecast Period: | 2022 to 2030 |
| Forecast Period 2022 to 2030 CAGR: | 10.4% | 2030 Value Projection: | US$ 12,532.8 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
General Electric, BD, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH., Sysmex Corporation, Agilent Technologies, Inc., Danaher, Enzo Life Sciences, Inc., Cytek Biosciences, Sartorius AG, BioLegend, Inc., Beckman Coulter, Inc., Laboratory Corporation of America Holdings., and MilliporeSigma |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Figure 2. Global Flow Cytometry Market Value (US$ Million), by Region, 2022
Global Flow Cytometry Market – Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.
COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.
However, the COVID-19 pandemic had a positive impact on the global flow cytometry market. For instance, in August 2020, according to the data published in Springer, flow cytometry analysis of peripheral blood mononuclear cell (PBMC) phenotype helped to predict the risk of clinical progression of COVID-19 and indicated that recovery from COVID-19 is accompanied by improved antigen presentation and more effective adaptive immune responses.
Global Flow Cytometry Market: Key Developments
Increasing adoption of inorganic strategies such as product launch by key market players is expected to drive global flow cytometry market. For instance, in June 2022, Sysmex Corporation, a medical device company, announced that they had launched XF-1600 flow cytometer that provides improved flexibility and efficiency for a wide range of applications in diagnostic applications.
Global Flow Cytometry Market: Restraint
Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration is expected to hinder the market growth. For instance, in November 2018, the U.S. Food and Drug Administration recalled a class I flow cytometers, which is manufactured by Beckman Coulter, Inc., a manufacturer of diagnostic systems. The flow cytometers was recalled due to electrical circuit error that deliver inaccurate assessments of cells taken from patients with blood cancers, HIV and other serious hematological diseases.
Global Flow Cytometry Market - Key Players
Major players operating in the global flow cytometry market include General Electric, BD, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH., Sysmex Corporation, Agilent Technologies, Inc., Danaher, Enzo Life Sciences, Inc., Cytek Biosciences, Sartorius AG, BioLegend, Inc., Beckman Coulter, Inc., Laboratory Corporation of America Holdings., and MilliporeSigma
Flow cytometry is a laser-based technology employed in cell counting, cell sorting, biomarker detection, and protein engineering. The process is conducted by suspending cells in a stream of fluid and passing them through an electronic detection apparatus. The simultaneous multi-parametric analysis of the physical and chemical characteristics of particles is facilitated by a flow cytometer at a speed of up to thousands of particles per second. The process is used in the diagnosis of health disorders such as blood cancers along with several applications in basic research, clinical practice, and clinical trials. Flow cytometry uses fluorescent probes to identify and characterize cells or particles. Flow cytometry facilitates study of the expression of cell surface and intracellular molecules along with characterization of different cell types in a heterogeneous cell population. Moreover, flow cytometry also allows simultaneous multi-parameter analysis of single cells. The combination of technological improvements, growing research activities in life science, and increasing clinical application of flow cytometry in diagnosis of HIV and cancer are some of the major factors that are expected to drive growth of the flow cytometry market over the forecast period.
Market Dynamics
Increasing number of inorganic strategies such as product launch by the key market players is expected to drive the global flow cytometry market over the forecast period. For instance, in April 2022, Beckman Coulter, Inc., a manufacturer of diagnostic systems, announced that they had launched CellMek SPS, a fully automated sample preparation system for clinical flow cytometry, which offers on-demand processing and a continuous output of samples to analyze with full traceability.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients